måndag 8 maj 2017

About (DextroPropoxyphene): Sweden thus lead Europe on this issue ( that means us)

Excerpt from this article:

European Medicines Evaluation Agency bans dextropropoxyphene: a landmark decision for clinical toxicology? 


Journal Clinical Toxicology  Volume 47, 2009 - Issue 8

There was also an active campaign in Sweden where there was concern about underdetection of associated deaths (6). A decision not to renew a 5-year marketing licence extension had been taken in Spring 2004 and in autumn 2005 dextropropoxyphene became unavailable following a campaign that focussed on its toxicity in overdose (7). Sweden thus lead Europe on this issue."

Bateman DN, Sandilands EA

Inga kommentarer:

Skicka en kommentar